| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |